150 related articles for article (PubMed ID: 215515)
1. Histopathological types of nasopharyngeal carcinoma in a low-risk area: Japan.
Sugano H; Sakamoto G; Sawaki S; Hirayama T
IARC Sci Publ (1971); 1978; (20):27-39. PubMed ID: 215515
[TBL] [Abstract][Full Text] [Related]
2. Histological types of nasopharyngeal carcinoma in an intermediate risk area.
Cammoun M; Ellouz R; Behi J; Attia RB
IARC Sci Publ (1971); 1978; (20):13-26. PubMed ID: 215511
[TBL] [Abstract][Full Text] [Related]
3. Histological typing of nasopharyngeal carcinoma.
Shanmugaratnam K
IARC Sci Publ (1971); 1978; (20):3-12. PubMed ID: 215516
[TBL] [Abstract][Full Text] [Related]
4. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
[TBL] [Abstract][Full Text] [Related]
5. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
Wilmes E; Wolf H; Deinhardt F; Naumann HH
Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
[TBL] [Abstract][Full Text] [Related]
6. Histopathological and immunological studies of nasopharyngeal carcinoma.
Sawaki S; Sugano H; Hirayama T; Kawamura A; Tachibana T
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Jun; 8(2):73-81. PubMed ID: 1243122
[TBL] [Abstract][Full Text] [Related]
7. [Carcinomas of the nasopharynx. Relationship between histological type and anti-Epstein-Barr virus serology (author's transl)].
Micheau C; de The G; Orofiamma B; Schwaab G; Brugere J; Tursz T; Sancho-Garnier H; Cachin Y
Nouv Presse Med; 1980 Jan; 9(1):21-4. PubMed ID: 6243770
[TBL] [Abstract][Full Text] [Related]
8. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
[TBL] [Abstract][Full Text] [Related]
9. [Immunoglobulin A serum antibodies against the capsid antigen of Epstein-Barr virus in the differential diagnosis and follow-up of nasopharyngeal cancer].
Pavelka R; Popow-Kraupp T; Radaszkiewicz T
Wien Klin Wochenschr; 1985 Jul; 97(14):588-95. PubMed ID: 2996246
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand.
Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P
Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381
[TBL] [Abstract][Full Text] [Related]
11. The histopathological spectrum of nasopharyngeal carcinoma.
Weiland LH
IARC Sci Publ (1971); 1978; (20):41-50. PubMed ID: 730199
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of malignant tumours of the nasopharynx in France: retrospective and prospective studies.
Brugere J; Point D; Sancho-Garnier H; Schwaab G
IARC Sci Publ (1971); 1978; (20):241-9. PubMed ID: 730192
[TBL] [Abstract][Full Text] [Related]
14. Malaria antibody levels in patients with nasopharyngeal carcinoma.
Yadav M; Prasad U
Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
[TBL] [Abstract][Full Text] [Related]
15. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma.
Nicholls JM; Agathanggelou A; Fung K; Zeng X; Niedobitek G
J Pathol; 1997 Oct; 183(2):164-8. PubMed ID: 9390028
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
17. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas.
de-The G; Lavoue MF; Muenz L
IARC Sci Publ (1971); 1978; (20):471-81. PubMed ID: 215529
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type.
Vaughan TL; Shapiro JA; Burt RD; Swanson GM; Berwick M; Lynch CF; Lyon JL
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):587-93. PubMed ID: 8824359
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.
Niedobitek G; Hansmann ML; Herbst H; Young LS; Dienemann D; Hartmann CA; Finn T; Pitteroff S; Welt A; Anagnostopoulos I
J Pathol; 1991 Sep; 165(1):17-24. PubMed ID: 1659626
[TBL] [Abstract][Full Text] [Related]
20. Nasopharyngeal carcinoma in children and adolescents in Tunisia: clinical aspects and the paraneoplastic syndrome.
Ellouz R; Cammoun M; Attia RB; Bahi J
IARC Sci Publ (1971); 1978; (20):115-29. PubMed ID: 730188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
